Get the latest Science News and Discoveries

NIH-sponsored trial of enterovirus D68 therapeutic begins - EurekAlert


The National Institutes of Health (NIH) is sponsoring a clinical trial to evaluate the safety of an investigational monoclonal antibody to treat enterovirus D68 (EV-D68), which can cause severe respiratory and neurological diseases such as acute flaccid myelitis (AFM) – similar to polio. Scientists are striving to better understand AFM, which has emerged in the United States with spikes in cases every other year, primarily in the late-summer months over the last decade. The U.S. Centers for Disease Control and Prevention (CDC) identified increases in AFM cases in 2014, 2016, and 2018. EV-D68 is a virus of growing public health concern due to its association with the intermittent AFM outbreaks. 

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of sponsored trial

sponsored trial

Photo of D68

D68

Related news:

News photo

Phytochemical diversity and herbivory are higher in tropical forests: Study - EurekAlert

News photo

Balancing act: Novel wearable sensors and AI transform balance assessment - EurekAlert

News photo

Potential new target for colorectal cancer treatment - EurekAlert